Dr Agarwal's Eye Hospital merges into Health Care Nov 1; the 23-for-2 swap was worth ~6% more at Oct 19 closes
The NCLT-sanctioned amalgamation turns effective November 1, 2026, record date November 18. Every 2 Eye Hospital shares (₹10 FV) convert into 23 Health Care shares (₹1 FV).
23 : 2
23 Health Care (₹1 FV) per 2 Eye Hospital (₹10 FV)
Nov 1, 2026
Appointed date Apr 1, 2026
Nov 18, 2026
Fixed at board meetings on Oct 20
₹5,079
Oct 19 close · mcap ≈ ₹2,455 Cr
₹468
Oct 19 close · mcap ≈ ₹14,835 Cr
SMALL-CAP
Eye Hospital, by market cap ≈ ₹2,455 Cr
On the evening of October 20, 2026 — after market close — Dr Agarwal's Eye Hospital and Dr. Agarwal's Health Care each filed the outcome of board meetings held that day: the scheme of amalgamation merging the Eye Hospital (the transferor) into Health Care (the transferee) becomes effective and operative from November 1, 2026, with an appointed date of April 1, 2026. The boards also fixed Wednesday, November 18, 2026 as the record date for determining the Eye Hospital shareholders entitled to receive consideration shares of Health Care. Because both filings reached the exchange after the close (18:50–19:46 IST), the first session in which they could be traded is October 21 — the price series available to this report ends October 19, so no market reaction to the record-date news is shown here.
The mechanics of the swap
Record date fixed at November 18; scheme effective November 1
The Eye Hospital board took the certified NCLT order dated September 30, 2026 on record and noted that, with the certified order filed with the Registrar of Companies in Form INC-28, all conditions under Clause 24 of the Scheme stand satisfied. The exchange ratio: 23 fully paid-up equity shares of ₹1 face value in Dr. Agarwal's Health Care for every 2 fully paid-up equity shares of ₹10 face value in Dr. Agarwal's Eye Hospital. On effectiveness, the Eye Hospital stands dissolved without being wound up and its board ceases to exist; its status at the Registrar of Companies changes to "Amalgamated". Filed at 19:46 IST, after market close.
Read:This converts a court-approved scheme into a dated timetable. Eye Hospital holders now know exactly when their shares stop being Eye Hospital shares — and what they get in exchange.
BSE filing, Oct 20 — Eye Hospital record-date fixationNCLT Chennai sanctions the scheme of amalgamation
The Eye Hospital informed the exchange that the National Company Law Tribunal, Chennai Bench, had sanctioned the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital and Dr. Agarwal's Health Care and their respective shareholders and creditors, under Sections 230 to 232 of the Companies Act, 2013. Filed at 22:51 IST, after market close.
Read:The sanction was the last judicial step; everything since has been procedural — filing the order with the Registrar of Companies and setting dates.
BSE filing, Oct 5 — receipt of NCLT sanctionThe headline ratio of 23-for-2 works out to 11.5 Health Care shares per Eye Hospital share — but the two instruments are not like-for-like. Eye Hospital shares carry a ₹10 face value; the Health Care shares being issued carry a ₹1 face value. The filings state the ratio only in the 2-share lot form, and they do not state how fractional entitlements will be treated for a holder with an odd number of shares. What the ratio is worth, at the last closes available before the record-date announcement, is simple arithmetic:
Computed from split/bonus-adjusted BSE closing prices of October 19, 2026 — the last session before the record-date filings. Both prices can move before the November 18 record date.
At those closes, the consideration shares were worth about 6% more than the Eye Hospital shares they replace. That gap is an observation, not a guarantee — possible explanations include the Eye Hospital's very thin trading (volumes in its last ten sessions ranged from 23 to 286 shares a day, against 84,549 for Health Care on October 19 alone), and the fact that these closes predate the record-date announcement. Whether the gap narrows as November 18 approaches is one of the things worth watching.
From court order to record date
- 1
NCLT sanctions the scheme
Sep 30The NCLT, Chennai Bench passes its order dated September 30, 2026 sanctioning the Scheme under Sections 230–232 of the Companies Act, 2013.
- 2
Sanction intimated to exchanges
Oct 5Both companies inform the exchange of the NCLT sanction on October 5, 2026, after market close.
- 3
Certified order filed with the Registrar of Companies
Oct 14–15The certified NCLT order is filed in Form INC-28 with the ROC, Chennai — the Eye Hospital's filing states October 14, 2026; Health Care's states October 15, 2026. With this, all conditions under Clause 24 of the Scheme stand satisfied.
- 4
Boards fix the record date
Oct 20At board meetings on October 20, 2026, both companies take the order on record, declare the scheme effective from November 1, and fix November 18, 2026 as the record date.
- 5
Scheme becomes effective
Nov 1The Eye Hospital stands dissolved without being wound up; its board ceases to exist and its status changes to "Amalgamated" at the Registrar of Companies. Its authorised capital merges into Health Care's.
- 6
Record date for allotment
Nov 18Eligible Eye Hospital shareholders on this date receive 23 Health Care shares of ₹1 face value for every 2 Eye Hospital shares of ₹10 face value held.
The capital-structure plumbing is spelled out in Health Care's filing. The Eye Hospital's authorised capital of 2,00,00,000 equity shares of ₹10 each stands reclassified into 20,00,00,000 equity shares of ₹1 each, and on November 1 that ₹20 crore of authorised capital merges automatically into Health Care's. Health Care's authorised equity capital rises from 54,20,00,000 shares of ₹1 (₹54.2 crore) to 74,20,00,000 shares of ₹1 (₹74.2 crore), taking total authorised capital from ₹90 crore to ₹110 crore including the existing ₹35.8 crore of convertible preference capital. The filings do not state the number of consideration shares that will actually be allotted, or how Health Care's own holding in its subsidiary will be treated in the allotment — Health Care's August 27 filing describes the Eye Hospital as its subsidiary, and the Eye Hospital's shareholding pattern shows a 72.67% promoter holding.
A thin stock heading into its last fortnight
The Eye Hospital's last close of ₹5,079 sits 20.5% below its 52-week adjusted high of ₹6,392 (January 2, 2026) and 15.1% above the 52-week low of ₹4,412.05 (January 30, 2026). The NCLT sanction itself barely moved the stock — the first session after the October 5 intimation closed 0.5% lower. Health Care closed October 19 at ₹468, which is 17.6% below its 52-week high of ₹567.75 (August 11, 2026) and 16.7% above its low of ₹401 (March 30, 2026). From here, every move in Health Care's price mechanically changes what the consideration is worth to an Eye Hospital holder.
The Eye Hospital reports standalone; Health Care's figures are consolidated. Source: quarterly results and shareholding patterns as filed.
Both businesses went into the merger growing. The Eye Hospital's Q1 FY27 standalone revenue of ₹142.97 crore was up 22.3% over the ₹116.92 crore of Q1 FY26, with net profit up 35.5% to ₹23.38 crore; Health Care's consolidated Q1 FY27 revenue of ₹614.02 crore was up 26.0% year-on-year, with net profit up 44.6% to ₹55.02 crore. Since Health Care's own filings describe the Eye Hospital as its subsidiary, its consolidated numbers would already reflect the subsidiary's operations to the extent it is consolidated — which suggests the amalgamation reshapes the legal structure and the share register more than the consolidated profit and loss. That reading is an inference; the filings themselves describe only the scheme mechanics.
The dates that settle this
Nov 1
Effectiveness: the Eye Hospital dissolves without winding up, its board ceases, and its ROC status changes to "Amalgamated". The filings in hand do not state a last trading date for the 526783 scrip — watch for an exchange notice on trading cessation.
Nov 18
Record date. The allotment disclosure that follows should settle what the filings leave open: the exact number of consideration shares issued, the treatment of fractional entitlements, and how Health Care's own holding in the Eye Hospital is handled.
The spread
Whether the ~6% gap between 23 Health Care shares and 2 Eye Hospital shares (at October 19 closes) narrows as the record date approaches — in a stock that trades a few hundred shares a day, the gap may say more about liquidity than mispricing.
Q2 FY27 results
Both companies closed their trading windows from September 30, 2026 ahead of results for the quarter and half-year ended September 30. The Eye Hospital's would be its last as a listed company.
The event itself holds no suspense — the scheme is sanctioned, the conditions are satisfied, and the dates are fixed. What remains for an Eye Hospital shareholder is arithmetic and logistics: 23 Health Care shares of ₹1 face value for every 2 shares held on November 18, in exchange for a stock that stops existing on November 1. At October 19 closes that consideration was worth about 6% more than the shares being given up, though both legs of that comparison can move.
The larger question — what the combined entity is worth — now rests entirely on Health Care's tape, where a ₹14,835 crore mid-cap absorbs its ₹2,455 crore subsidiary. The allotment disclosures after the record date, and the first results of the combined entity, are where the data will next say something new.
Informational and educational content only. Not investment advice.